<DOC>
	<DOCNO>NCT00251407</DOCNO>
	<brief_summary>The purpose study find high dose combination taxotere , cisplatin CPT-11 , give without cause severe side effect . We also want test safety drug combination see effect ( good bad ) patient advanced cancer know curable treatment .</brief_summary>
	<brief_title>Taxotere , Cisplatin , CPT-11 Advanced Solid Tumor Malignancies</brief_title>
	<detailed_description>- This Phase I clinical trial . We unsure safe effective dose drug therefore plan treat 3-6 patient give dose increase high dose level . - Each patient receive approximately two cycle therapy . On day one day eight , receive taxotere , cisplatin CPT-11 intravenously . The cycle begin day 22 . - The following test procedure perform : CAT scan prior begin therapy , every 2 cycle therapy , end study ; physical exam course therapy ; vital sign dose therapy ; routine blood test start therapy weekly treatment ; chest x-ray echocardiogram start therapy ; toxicity assessment week therapy . - Patients remain study long cancer respond treatment unacceptable side effect .</detailed_description>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologically confirm , incurable solid tumor malignancy 18 year age old ECOG performance status &lt; = 2 Life expectancy great 12 week WBC &gt; 3,000/mm3 ANC &gt; 1,500/mm3 Platelet count &gt; 100,000/mm3 Total bilirubin within normal limit SGOT &lt; 2.5 x ULN Alkaline phosphatase &lt; 4 x ULN Prior chemotherapy treatment metastatic recurrent cancer Prior radiotherapy great equal 15 % bone marrow Prior pelvic radiation therapy Prior nitrosoureas mitomycin C Myocardial infarction past 6 month Major surgery past 2 week Uncontrolled serious medical psychiatric illness Uncontrolled diarrhea Peripheral neuropathy &gt; grade 1 Pregnant lactate woman Clinically apparent central nervous system metastases carcinomatous meningitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Advanced solid tumor malignancy</keyword>
	<keyword>cisplatin</keyword>
	<keyword>CPT-11</keyword>
	<keyword>taxotere</keyword>
</DOC>